Search
SOLACI Congress
HomeFile

File

View Category
Coronary disease

Coronary Events after TAVI according to the FRANCE Registry

Between 30% and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present with coronary artery disease...
Dr. Andrés Rodríguez -
Learn More
Acute coronary syndromes

Use of OCT in Calcified Lesions: Results from a Subanalysis of ILUMIEN IV

Coronary calcification represents one of the main challenges in percutaneous coronary intervention (PCI), as it is associated...
Dr. Omar Tupayachi -
Learn More
Chronic Coronary Syndromes

Microvascular Dysfunction in Patients with Positive Coronary CT Angiography: Implications of Invasive Physiological Studies

Both European and US clinical guidelines recommend coronary CT angiography as the starting diagnostic study when coronary...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Should Early Aortic Valve Replacement Be Indicated in Asymptomatic Severe Aortic Stenosis?

A Meta-Analysis of Randomized Clinical Trials. The management of aortic stenosis in asymptomatic patients remains a matter of...
Dr. Juan Manuel Pérez -
Learn More
Chronic Coronary Syndromes

Angioplasty vs Carotid Endarterectomy: Systematic Review and Meta-Analysis of Randomized Clinical Trials

Courtesy of Dr. Juan Manuel Pérez. Carotid stenosis is a major risk factor for stroke. Its treatment includes...
Dr. Juan Manuel Pérez -
Learn More
Coronary disease

Provisional Angioplasty in Left Main: What MSA Values Should We Target?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) represents one of the most...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Predilatation in Self-Expanding Valves

TAVI has become the treatment of choice in specific scenarios. However, predilatation (PRD) remains a matter of...
Dr. Carlos Fava -
Learn More
Acute coronary syndromes

Flow Protocols in VA-ECMO: Impact on PCWP in Cardiogenic Shock

The use of peripheral femoro-femoral venoarterial (VA) extracorporeal membrane oxygenation (ECMO) has globally consolidated and is the...
Dr. Omar Tupayachi -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy